LL-K8-22

Produktübersicht

• Artikelname: LL-K8-22
• Artikelnummer: MCE-HY-149209
• Hersteller Artikelnummer: HY-149209
• Alternativnummer: MCE-HY-149209-50MG,MCE-HY-149209-5MG,MCE-HY-149209-10MG,MCE-HY-149209-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

LL-K8-22 is a potent, selective and durable CDK8-cyclin C dual degrader, with DC50 values of 2.52 and 2.64 µM, respectively. LL-K8-22 also suppresses STAT1 Ser 727 phosphorylation. LL-K8-22 inhibits E2F- and MYC-driven carcinogenic transcriptional progra

Produkteigenschaften

• Molekulargewicht: 573.77
• Reinheit: 99.76
• Formel: C37H43N5O
• Target-Kategorie: CDK,Early 2 Factor (E2F),STAT

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound